Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07461116) titled 'Adverse Effects of ATG/ALG Therapy in Aplastic Anemia' on Feb. 24.
Study Type: Observational
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Condition:
Aplastic Anaemia
Intervention:
Drug: ATG/ALG
Recruitment Status: Recruiting
Date of First Enrollment: February 23, 2026
Target Sample Size: 200
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07461116
Disclaimer: Curated by HT Syndication....